nAChR Antagonist Explorer Kit

A Screening Package of nAChR Blockers Economically Priced
  • Lyophilized Powder
  • Bioassay Tested
Cat #: EK-205
Sizes: 19 Vials
Last update: 04/09/2019

Alomone Labs is pleased to offer the nAChR Antagonist Explorer Kit (#EK-205). This Explorer Kit includes nAChR antagonists, ideal for screening purposes.

For research purposes only, not for human use
Compounds
Product NameCat #Size
Azemiopsin
STA-100 1 x 0.1 mg
α-Bungarotoxin
B-100 1 x 0.5 mg
Chlorpromazine hydrochloride
C-165 1 x 5 g
αA-Conotoxin OIVA
STC-520 1 x 10 µg
αA-Conotoxin PIVA
STC-600 1 x 50 µg
αC-Conotoxin PrXA
STC-620 1 x 50 µg
α-Conotoxin AuIA
STC-960 1 x 0.25 mg
α-Conotoxin AuIB
STC-310 1 x 0.1 mg
α-Conotoxin EI
STC-900 1 x 0.1 mg
α-Conotoxin GI
STC-500 1 x 50 µg
α-Conotoxin ImI
C-290 1 x 0.1 mg
α-Conotoxin LtIA
STC-550 1 x 0.5 mg
α-Conotoxin MI
STC-370 1 x 0.1 mg
α-Conotoxin PeIA
STC-970 1 x 0.1 mg
α-Conotoxin PIA
STC-870 1 x 50 µg
Huwentoxin-I
STH-050 1 x 50 µg
(-)-Lobeline hydrochloride
L-120 1 x 100 mg
Mecamylamine hydrochloride
M-105 1 x 5 mg
Pancuronium bromide
P-130 1 x 25 mg
References
    • Acetylcholine, released by cholinergic neurons, activates two groups of acetylcholine receptors (AChRs); muscarinic AChRs (mAChRs) which belong to the superfamily of G-protein coupled receptors (GPCRs) and nicotinic AChRs (nAChRs) which belong to the ligand-gated ion channel superfamily. nAChRs also respond to nicotine, hence their name1.

      To date, 17 different but related subunits of nAChRs have been identified and cloned. They consist of α subunits (α1-10), which is responsible for the binding of ligands. In fact, this subunit includes a Cys-loop in the first extracellular domain that is required for agonist binding2. The other subunits responsible for making up the active receptor are the β (β1-4), γ, δ and ε subunits3. Structurally, all subunits have the following: a conserved large extracellular N-terminal domain, 3 conserved transmembrane domains, a variable cytoplasmic loop and a fourth transmembrane domain with a short extracellular C-terminal domain.  An active nAChR is generally a heteropentamer of these various subunits organized around a central pore1.

      nAChRs are validated therapeutic targets for various CNS pathologies4.

Related Products